Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00095394
Status:
COMPLETED
Last Update Posted:
2011-04-15
First Post:
2004-11-03
Brief Title:
IrbesartanHydrochlorothiazide HCTZ Combination Therapy as First Line Treatment for Severe Hypertension
Sponsor:
Organization:
Bristol-Myers Squibb